Cargando…

Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma

SIMPLE SUMMARY: In this study, we evaluated the association of immune mediated thyroid dysfunction (irT) with survival in 123 metastatic renal cell carcinoma patients treated with immunotherapy in a single center. We found that irT is a prevalent and early event associated with prolonged survival in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagie, Shira, Gadot, Moran, Levartovsky, Meital, Gantz Sorotsky, Hadas, Berger, Raanan, Sarfaty, Michal, Percik, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870210/ https://www.ncbi.nlm.nih.gov/pubmed/35205622 http://dx.doi.org/10.3390/cancers14040875

Ejemplares similares

RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
por: Sagie, Shira, et al.
Publicado: (2022)

Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer
por: Gadot, Moran, et al.
Publicado: (2020)

Response to Anti-PD1/L1 Antibodies in Advanced Urothelial Cancer in the ‘Real-Life’ Setting
por: Gadot, Moran, et al.
Publicado: (2022)

Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit
por: Haberman, Yael, et al.
Publicado: (2023)

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer
por: Nisman, Benjamin, et al.
Publicado: (2016)

Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone
por: Saad, Akram, et al.
Publicado: (2022)

Characteristics of Immune Checkpoint Inhibitors Trials Associated With Inclusion of Patients With HIV: A Systematic Review and Meta-analysis
por: Sorotsky, Hadas, et al.
Publicado: (2019)

Survival and Success Rates of Monolithic Zirconia Restorations Supported by Teeth and Implants in Bruxer versus Non-Bruxer Patients: A Retrospective Study
por: Heller, Hadas, et al.
Publicado: (2022)

Early death after a diagnosis of metastatic solid cancer–raising awareness and identifying risk factors from the SEER database
por: Globus, Opher, et al.
Publicado: (2023)

Metastatic renal cell carcinoma in the thyroid gland
por: Cruz, Mark M., et al.
Publicado: (2020)

Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival
por: Abu-Ghanem, Yasmin, et al.
Publicado: (2017)

Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing
por: Sehayek, Or, et al.
Publicado: (2022)

Convergence insufficiency: Review of clinical diagnostic signs
por: Gantz, Liat, et al.
Publicado: (2022)

Metastatic Thyroid Cancer Presenting as Renal Cortical Mass
por: Hasan, Osamah, et al.
Publicado: (2020)

Load-Bearing Capacity of Zirconia Crowns Screwed to Multi-Unit Abutments with and without a Titanium Base: An In Vitro Pilot Study
por: Heller, Hadas, et al.
Publicado: (2019)

Predictors of Progression-Free Survival and Overall Survival in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Single-Center Experience
por: Barua, Sasanka Kumar, et al.
Publicado: (2019)

Renal Cell Carcinoma Metastatic to Thyroid Gland, Presenting Like Anaplastic Carcinoma of Thyroid
por: Riaz, Khalid, et al.
Publicado: (2013)

A Case of Metastatic Renal Cell Carcinoma to Thyroid Gland
por: Lee, Jae-Geun, et al.
Publicado: (2011)

Outcomes and Complications of 33 Soft-Milled Cobalt-Chromium-Ceramic Full-Arch Screw-Retained Implant-Supported Prostheses: A Retrospective Study with up to 10-Year Follow-Up
por: Heller, Hadas, et al.
Publicado: (2023)

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
por: Keizman, Daniel, et al.
Publicado: (2016)

Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
por: Percik, Ruth, et al.
Publicado: (2023)

Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis
por: Wang, Zhan, et al.
Publicado: (2019)

Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
por: Rouvinov, Keren, et al.
Publicado: (2023)

Metastatic Renal Cell Carcinoma to the Thyroid 23 Years After Nephrectomy()
por: Valdez, Carrie, et al.
Publicado: (2014)

Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients
por: Laufer, Menachem, et al.
Publicado: (2023)

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)

Retrospective 1- to 8-Year Follow-Up Study of Complete Oral Rehabilitation Using Monolithic Zirconia Restorations with Increased Vertical Dimension of Occlusion in Patients with Bruxism
por: Matalon, Shlomo, et al.
Publicado: (2022)

Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy
por: Mizuno, Ryuichi, et al.
Publicado: (2022)

Rapid characterization of secreted recombinant proteins by native mass spectrometry
por: Ben-Nissan, Gili, et al.
Publicado: (2018)

Case Report: Metastatic renal cell carcinoma to the thyroid— A rare encounter
por: Shepherd, Megan, et al.
Publicado: (2022)

ODP512 Renal Cell Carcinoma Metastatic to Thyroid: A Case Report
por: XU, Shiming, et al.
Publicado: (2022)

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia
por: Jürgens, Hannes, et al.
Publicado: (2020)

Impact of Body Mass Index on Survival of Metastatic Renal Cancer
por: Plonski, Jose Javier Salgado, et al.
Publicado: (2021)

Diagnostic criteria and proposed management of immune-related endocrinopathies following immune checkpoint inhibitor therapy for cancer
por: Percik, Ruth, et al.
Publicado: (2023)

Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery
por: Appel, Sarit, et al.
Publicado: (2023)

Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer
por: Chrisoulidou, Alexandra, et al.
Publicado: (2011)

Repeat laser interstitial thermal therapy for recurrent primary and metastatic intracranial tumors
por: Muir, Matthew, et al.
Publicado: (2022)

BSCI-26. COMPARATIVE METHYLATION PROFILING OF EGFR MUTANT LUNG ADENOCARCINOMA AND PAIRED BRAIN METASTASIS
por: Mamatjan, Yasin, et al.
Publicado: (2019)

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
por: Aziz, Saadia A, et al.
Publicado: (2014)

Sociodemographic Predictors of Survival in Differentiated Thyroid Cancer: Results from the SEER Database
por: Johnston, Lily E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ptdsc111gdnq1hcuga4gvugh16